Study of BMS-650032 With Peginterferon Alfa-2a Plus Ribavirin

Clinical trial NCT01030432 · COMPLETED

Trial details

NCT number: NCT01030432
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatitis C Virus

Start date: 2010-02-01
Primary completion: 2012-10-01
Enrollment: 285

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.